查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1868005

聚脫氧核苷酸（PDRN）－全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Polydeoxyribonudeotide (PDRN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球聚脫氧核糖核苷酸 (PDRN) 市場規模估計為 7,210 萬美元，預計到 2031 年將達到 5.4 億美元，在預測期（2025-2031 年）內以 32.5% 的複合年成長率成長。

本報告對近期關稅調整和國際戰略反制措施，以及多脫氧核糖核苷酸（PDRN）的跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組進行了全面評估。

PDRN是一種主要提取自魚類精液和卵巢的去氧核糖核酸（DNA）產品。它能快速修復受損疤痕組織，促進細胞表面膠原蛋白合成，進而逆轉老化過程。作為一種卓越的皮膚修復成分，PDRN被廣泛應用於從高階美容產品到醫療產品等各類產品。其強大的抗輻射和收縮毛孔功效，能讓肌膚更加亮澤、有彈性。

聚脫氧核苷酸（PDRN）和多核苷酸（PN）是從鮭魚、鱒魚和其他魚類的再生細胞（精子和睪丸）的遺傳片段（DNA）中提取的再生材料。 PDRN和PN的分子大小不同（PN較大），皆為經食品藥物安全部核准的安全生物來源製劑。 PDRN廣泛應用於醫藥領域，用於組織再生、角膜再生、傷口護理和組織修復；而PN則廣泛應用於醫療設備（組織再生）領域，用於皮膚修復、關節軟骨再生和骨骼形成。

本報告包括 PDRN 和 PN。

作為一種再生醫學產品，PDRN能夠從受損或缺氧組織合成DNA，活化FGF、IGF和EGF等內源性生長因子的再生，促進細胞代謝，並提高皮膚的修復和再生能力。其富含膠原蛋白和彈性蛋白的纖維網路能夠實現活膚，改善皮膚微環境，增加皮膚厚度，從而改善問題肌膚。

近年來，PDRN市場呈現顯著成長趨勢，主要受再生醫學/組織工程和美容領域的推動。創傷治療、皮膚病學和整形外科等醫療領域對創新解決方案的需求，也推動了PDRN產品和治療方法的需求。

依產品類型分類，凍乾粉將佔據重要地位，預計到2024年將以65%的市佔率主導市場。這主要歸功於其在醫藥和化妝品領域的卓越穩定性和多功能性。同時，注射用PDRN溶液（例如中美塑療法）的需求也在成長，尤其是在韓國，其在「鮭魚針」療法中的應用尤為廣泛。由於其臨床應用簡便，預計需求將大幅成長。按應用領域分類，預計到2024年，PDRN在醫學美容（美塑療法）領域的市場佔有率將達到約32%，主要用於「再生水凝膠」中，以促進膠原蛋白合成並發揮抗發炎作用。

全球主要的聚脫氧核糖核苷酸（PDRN）生產商包括HTL Biotechnology、瑞吉明生物、醫藥研究有限公司、Humedix、ReaLi Tide Biological、恆宇生物、Mastelli、東國生物、BR PHARM、BMI KOREA、BNF Solution等。到2024年，全球前三大供應商的收入佔有率將佔約56%。

作為一種新型再生醫學材料，PDRN具有多種活性，包括促進皮膚損傷修復、抗發炎、促進血管生成和改善組織微循環。預計將在醫療設備、藥品、化妝品、保健食品、日化產品和醫美等領域廣泛應用。隨著醫美消費的成長和應用領域的拓展，PDRN市場預計未來將進一步擴大。憑藉其在亞太地區（韓國和中國）的主導地位以及向化妝品和創傷護理領域的多元化發展，PDRN市場預計將迎來爆發式成長。關鍵發展因素包括中國放寬管制、植物來源材料的創新以及「再生美容」理念的興起。

本報告旨在按地區/國家、類型和應用對全球聚脫氧核糖核苷酸 (PDRN) 市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

聚脫氧核苷酸（PDRN）市場規模、估算和預測以銷售量（公斤）和收入（百萬美元）為單位呈現，以2024年為基準年，並包含2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定聚脫氧核苷酸（PDRN）的業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • HTL Biotechnology
  • ReaLi Tide Biological
  • PharmaResearch Co., Ltd.
  • Humedix
  • Ruijiming Biological
  • Bloomage Biotech
  • HENGYU BIOPH
  • Mastelli
  • Dongkook
  • BR PHARM
  • BNC Global
  • BMI KOREA
  • BNF Solution
  • Nanjing Letop Biotechnology
  • Topscience Biotech
  • Freda Biotechnology
  • Shebah Biotech
  • APR Corporation
  • Kolmar Korea
  • PORIBIO INC.

按類型分類的細分市場

  • 粉末
  • 解決方案

應用領域

  • 美塑療法
  • 骨注射和皮膚填充
  • 製藥
  • 化妝品
  • 創傷治療產品及其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Polydeoxyribonudeotide (PDRN) was estimated to be worth US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polydeoxyribonudeotide (PDRN) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

PDRN is deoxyribonucleic acid(DNA) product, mainly comes from semen and roe of fish, rapidly repair injured scars. It can promote the collagen synthesis on the cell surface, reverse aging signs. PDRN is the excellent skin repair product widely used for both high-end beauty products and medical products. Strong functions of anti-radiation and shrinking pores, make skin appears brightly and elastically.

Polydeoxyribonucleotide (PDRN) and polynucleotide (PN) are regenerative materials extracted from the regenerative cell (sperm and testicle) gene segment (DNA) of salmon or trout. The molecular sizes of PDRN and PN are different (PN is bigger) and they are safe biogenic substances approved by the Ministry of Food and Drug Safety. PDRN are often used in pharmaceuticals for tissue regeneration and cornea regeneration as well as treatment and tissue restoration of wounds. PN is often used for medical devices (tissue regeneration) for skin regeneration, articular cartilage regeneration, and osteogenic tissues.

Both PDRN and PN are included in the report.

As a product of regenerative medicine, PDRN can synthesize DNA from damaged or hypoxic tissues, activate the regeneration of endogenous growth factors such as FGF, IGF, and EGF, accelerate cell metabolism, and improve skin repair and regeneration capabilities. The fiber network full of collagen and elastin can achieve skin rejuvenation, improve skin microenvironment, increase skin thickness, etc., so as to achieve the effect of improving problem skin.

The PDRN market has shown a significant growth trend in recent years, mainly driven by the field of regenerative medicine and tissue engineering, as well as the field of aesthetics. Demand for innovative solutions in medical fields such as wound healing, dermatology, orthopedics is driving the demand for PDRN products and therapies.

In terms of product types, freeze-dried powder occupies an important position, dominated with 65% market share in 2024, preferred for stability and versatility in pharmaceuticals and cosmetics. While PDRN Solutions are growing demand in injectables (e.g., mesotherapy), especially in Korea's "salmon needle" treatments. Expected to surge due to ease of clinical applicationAt the same time, in terms of application, the share of Medical Aesthetics (Mesotherapy) in 2024 is about 32%, used in "regenerative hydrogels" for collagen synthesis and anti-inflammatory effects.

The major global manufacturers of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology, Ruijiming Biological, PharmaResearch Co., Ltd., Humedix, ReaLi Tide Biological, HENGYU BIOPH, Mastelli, Dongkook, BR PHARM, BMI KOREA, BNF Solution, etc. In 2024, the world's top three vendors accounted for approximately 56% of the revenue.

As a new type of regenerative material, PDRN has multiple activities such as promoting skin damage repair, anti-inflammatory, promoting angiogenesis, improving tissue microcirculation, etc. It has broad application prospects in the fields of medical devices, medicine, cosmetics, health foods, daily chemical products, medical cosmetology, etc. In the future, with the rise of medical beauty consumption and the expansion of application fields, the scale of the PDRN market will further expand. The PDRN market is poised for explosive growth, anchored by Asia-Pacific's dominance (Korea/China) and diversification into cosmetics/wound care. Key developments include China's regulatory openings, plant-based innovations, and the rise of "regenerative aesthetics."

This report aims to provide a comprehensive presentation of the global market for Polydeoxyribonudeotide (PDRN), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polydeoxyribonudeotide (PDRN) by region & country, by Type, and by Application.

The Polydeoxyribonudeotide (PDRN) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polydeoxyribonudeotide (PDRN).

Market Segmentation

By Company

  • HTL Biotechnology
  • ReaLi Tide Biological
  • PharmaResearch Co., Ltd.
  • Humedix
  • Ruijiming Biological
  • Bloomage Biotech
  • HENGYU BIOPH
  • Mastelli
  • Dongkook
  • BR PHARM
  • BNC Global
  • BMI KOREA
  • BNF Solution
  • Nanjing Letop Biotechnology
  • Topscience Biotech
  • Freda Biotechnology
  • Shebah Biotech
  • APR Corporation
  • Kolmar Korea
  • PORIBIO INC.

Segment by Type

  • Powder
  • Solution

Segment by Application

  • Mesotherapy
  • Bone Injection & Dermal Fillers
  • Pharmaceutical
  • Cosmetic
  • Wound Healing Products and Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Polydeoxyribonudeotide (PDRN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Polydeoxyribonudeotide (PDRN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Polydeoxyribonudeotide (PDRN) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Polydeoxyribonudeotide (PDRN) Product Introduction
  • 1.2 Global Polydeoxyribonudeotide (PDRN) Market Size Forecast
    • 1.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value (2020-2031)
    • 1.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume (2020-2031)
    • 1.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Price (2020-2031)
  • 1.3 Polydeoxyribonudeotide (PDRN) Market Trends & Drivers
    • 1.3.1 Polydeoxyribonudeotide (PDRN) Industry Trends
    • 1.3.2 Polydeoxyribonudeotide (PDRN) Market Drivers & Opportunity
    • 1.3.3 Polydeoxyribonudeotide (PDRN) Market Challenges
    • 1.3.4 Polydeoxyribonudeotide (PDRN) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Polydeoxyribonudeotide (PDRN) Players Revenue Ranking (2024)
  • 2.2 Global Polydeoxyribonudeotide (PDRN) Revenue by Company (2020-2025)
  • 2.3 Global Polydeoxyribonudeotide (PDRN) Players Sales Volume Ranking (2024)
  • 2.4 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Company Players (2020-2025)
  • 2.5 Global Polydeoxyribonudeotide (PDRN) Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Polydeoxyribonudeotide (PDRN) Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Polydeoxyribonudeotide (PDRN) Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Polydeoxyribonudeotide (PDRN)
  • 2.9 Polydeoxyribonudeotide (PDRN) Market Competitive Analysis
    • 2.9.1 Polydeoxyribonudeotide (PDRN) Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Polydeoxyribonudeotide (PDRN) Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polydeoxyribonudeotide (PDRN) as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Powder
    • 3.1.2 Solution
  • 3.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Type
    • 3.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type
    • 3.3.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Polydeoxyribonudeotide (PDRN) Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Mesotherapy
    • 4.1.2 Bone Injection & Dermal Fillers
    • 4.1.3 Pharmaceutical
    • 4.1.4 Cosmetic
    • 4.1.5 Wound Healing Products and Others
  • 4.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application
    • 4.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application
    • 4.3.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Polydeoxyribonudeotide (PDRN) Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region
    • 5.1.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2020-2025)
    • 5.1.3 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2026-2031)
    • 5.1.4 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (%), (2020-2031)
  • 5.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region
    • 5.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2020-2025)
    • 5.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2026-2031)
    • 5.2.4 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Polydeoxyribonudeotide (PDRN) Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 5.4.2 North America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 5.5.2 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 5.7.2 South America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.3.2 United States Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.4.2 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.5.2 China Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.6.2 Japan Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.7.2 South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
    • 6.9.2 India Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 HTL Biotechnology
    • 7.1.1 HTL Biotechnology Company Information
    • 7.1.2 HTL Biotechnology Introduction and Business Overview
    • 7.1.3 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.1.5 HTL Biotechnology Recent Development
  • 7.2 ReaLi Tide Biological
    • 7.2.1 ReaLi Tide Biological Company Information
    • 7.2.2 ReaLi Tide Biological Introduction and Business Overview
    • 7.2.3 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.2.5 ReaLi Tide Biological Recent Development
  • 7.3 PharmaResearch Co., Ltd.
    • 7.3.1 PharmaResearch Co., Ltd. Company Information
    • 7.3.2 PharmaResearch Co., Ltd. Introduction and Business Overview
    • 7.3.3 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.3.5 PharmaResearch Co., Ltd. Recent Development
  • 7.4 Humedix
    • 7.4.1 Humedix Company Information
    • 7.4.2 Humedix Introduction and Business Overview
    • 7.4.3 Humedix Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Humedix Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.4.5 Humedix Recent Development
  • 7.5 Ruijiming Biological
    • 7.5.1 Ruijiming Biological Company Information
    • 7.5.2 Ruijiming Biological Introduction and Business Overview
    • 7.5.3 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.5.5 Ruijiming Biological Recent Development
  • 7.6 Bloomage Biotech
    • 7.6.1 Bloomage Biotech Company Information
    • 7.6.2 Bloomage Biotech Introduction and Business Overview
    • 7.6.3 Bloomage Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Bloomage Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.6.5 Bloomage Biotech Recent Development
  • 7.7 HENGYU BIOPH
    • 7.7.1 HENGYU BIOPH Company Information
    • 7.7.2 HENGYU BIOPH Introduction and Business Overview
    • 7.7.3 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.7.5 HENGYU BIOPH Recent Development
  • 7.8 Mastelli
    • 7.8.1 Mastelli Company Information
    • 7.8.2 Mastelli Introduction and Business Overview
    • 7.8.3 Mastelli Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Mastelli Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.8.5 Mastelli Recent Development
  • 7.9 Dongkook
    • 7.9.1 Dongkook Company Information
    • 7.9.2 Dongkook Introduction and Business Overview
    • 7.9.3 Dongkook Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Dongkook Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.9.5 Dongkook Recent Development
  • 7.10 BR PHARM
    • 7.10.1 BR PHARM Company Information
    • 7.10.2 BR PHARM Introduction and Business Overview
    • 7.10.3 BR PHARM Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 BR PHARM Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.10.5 BR PHARM Recent Development
  • 7.11 BNC Global
    • 7.11.1 BNC Global Company Information
    • 7.11.2 BNC Global Introduction and Business Overview
    • 7.11.3 BNC Global Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 BNC Global Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.11.5 BNC Global Recent Development
  • 7.12 BMI KOREA
    • 7.12.1 BMI KOREA Company Information
    • 7.12.2 BMI KOREA Introduction and Business Overview
    • 7.12.3 BMI KOREA Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 BMI KOREA Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.12.5 BMI KOREA Recent Development
  • 7.13 BNF Solution
    • 7.13.1 BNF Solution Company Information
    • 7.13.2 BNF Solution Introduction and Business Overview
    • 7.13.3 BNF Solution Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 BNF Solution Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.13.5 BNF Solution Recent Development
  • 7.14 Nanjing Letop Biotechnology
    • 7.14.1 Nanjing Letop Biotechnology Company Information
    • 7.14.2 Nanjing Letop Biotechnology Introduction and Business Overview
    • 7.14.3 Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.14.5 Nanjing Letop Biotechnology Recent Development
  • 7.15 Topscience Biotech
    • 7.15.1 Topscience Biotech Company Information
    • 7.15.2 Topscience Biotech Introduction and Business Overview
    • 7.15.3 Topscience Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Topscience Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.15.5 Topscience Biotech Recent Development
  • 7.16 Freda Biotechnology
    • 7.16.1 Freda Biotechnology Company Information
    • 7.16.2 Freda Biotechnology Introduction and Business Overview
    • 7.16.3 Freda Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Freda Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.16.5 Freda Biotechnology Recent Development
  • 7.17 Shebah Biotech
    • 7.17.1 Shebah Biotech Company Information
    • 7.17.2 Shebah Biotech Introduction and Business Overview
    • 7.17.3 Shebah Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Shebah Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.17.5 Shebah Biotech Recent Development
  • 7.18 APR Corporation
    • 7.18.1 APR Corporation Company Information
    • 7.18.2 APR Corporation Introduction and Business Overview
    • 7.18.3 APR Corporation Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 APR Corporation Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.18.5 APR Corporation Recent Development
  • 7.19 Kolmar Korea
    • 7.19.1 Kolmar Korea Company Information
    • 7.19.2 Kolmar Korea Introduction and Business Overview
    • 7.19.3 Kolmar Korea Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Kolmar Korea Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.19.5 Kolmar Korea Recent Development
  • 7.20 PORIBIO INC.
    • 7.20.1 PORIBIO INC. Company Information
    • 7.20.2 PORIBIO INC. Introduction and Business Overview
    • 7.20.3 PORIBIO INC. Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 PORIBIO INC. Polydeoxyribonudeotide (PDRN) Product Offerings
    • 7.20.5 PORIBIO INC. Recent Development

8 Industry Chain Analysis

  • 8.1 Polydeoxyribonudeotide (PDRN) Industrial Chain
  • 8.2 Polydeoxyribonudeotide (PDRN) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Polydeoxyribonudeotide (PDRN) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Polydeoxyribonudeotide (PDRN) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Polydeoxyribonudeotide (PDRN) Market Trends
  • Table 2. Polydeoxyribonudeotide (PDRN) Market Drivers & Opportunity
  • Table 3. Polydeoxyribonudeotide (PDRN) Market Challenges
  • Table 4. Polydeoxyribonudeotide (PDRN) Market Restraints
  • Table 5. Global Polydeoxyribonudeotide (PDRN) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Polydeoxyribonudeotide (PDRN) Revenue Market Share by Company (2020-2025)
  • Table 7. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Polydeoxyribonudeotide (PDRN) Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Polydeoxyribonudeotide (PDRN) Price by Company (2020-2025) & (US$/g)
  • Table 10. Key Manufacturers Polydeoxyribonudeotide (PDRN) Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Polydeoxyribonudeotide (PDRN) Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Polydeoxyribonudeotide (PDRN)
  • Table 13. Global Polydeoxyribonudeotide (PDRN) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polydeoxyribonudeotide (PDRN) as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Polydeoxyribonudeotide (PDRN) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Polydeoxyribonudeotide (PDRN) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Polydeoxyribonudeotide (PDRN) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Polydeoxyribonudeotide (PDRN) Price by Type (2020-2025) & (US$/g)
  • Table 27. Global Polydeoxyribonudeotide (PDRN) Price by Type (2026-2031) & (US$/g)
  • Table 28. Global Polydeoxyribonudeotide (PDRN) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Polydeoxyribonudeotide (PDRN) Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Polydeoxyribonudeotide (PDRN) Price by Application (2020-2025) & (US$/g)
  • Table 39. Global Polydeoxyribonudeotide (PDRN) Price by Application (2026-2031) & (US$/g)
  • Table 40. Global Polydeoxyribonudeotide (PDRN) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Polydeoxyribonudeotide (PDRN) Average Price by Region (2020-2025) & (US$/g)
  • Table 51. Global Polydeoxyribonudeotide (PDRN) Average Price by Region (2026-2031) & (US$/g)
  • Table 52. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Volume, (2026-2031) & (Kg)
  • Table 57. HTL Biotechnology Company Information
  • Table 58. HTL Biotechnology Introduction and Business Overview
  • Table 59. HTL Biotechnology Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 60. HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 61. HTL Biotechnology Recent Development
  • Table 62. ReaLi Tide Biological Company Information
  • Table 63. ReaLi Tide Biological Introduction and Business Overview
  • Table 64. ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 65. ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 66. ReaLi Tide Biological Recent Development
  • Table 67. PharmaResearch Co., Ltd. Company Information
  • Table 68. PharmaResearch Co., Ltd. Introduction and Business Overview
  • Table 69. PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 70. PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 71. PharmaResearch Co., Ltd. Recent Development
  • Table 72. Humedix Company Information
  • Table 73. Humedix Introduction and Business Overview
  • Table 74. Humedix Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 75. Humedix Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 76. Humedix Recent Development
  • Table 77. Ruijiming Biological Company Information
  • Table 78. Ruijiming Biological Introduction and Business Overview
  • Table 79. Ruijiming Biological Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 80. Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 81. Ruijiming Biological Recent Development
  • Table 82. Bloomage Biotech Company Information
  • Table 83. Bloomage Biotech Introduction and Business Overview
  • Table 84. Bloomage Biotech Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 85. Bloomage Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 86. Bloomage Biotech Recent Development
  • Table 87. HENGYU BIOPH Company Information
  • Table 88. HENGYU BIOPH Introduction and Business Overview
  • Table 89. HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 90. HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 91. HENGYU BIOPH Recent Development
  • Table 92. Mastelli Company Information
  • Table 93. Mastelli Introduction and Business Overview
  • Table 94. Mastelli Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 95. Mastelli Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 96. Mastelli Recent Development
  • Table 97. Dongkook Company Information
  • Table 98. Dongkook Introduction and Business Overview
  • Table 99. Dongkook Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 100. Dongkook Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 101. Dongkook Recent Development
  • Table 102. BR PHARM Company Information
  • Table 103. BR PHARM Introduction and Business Overview
  • Table 104. BR PHARM Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 105. BR PHARM Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 106. BR PHARM Recent Development
  • Table 107. BNC Global Company Information
  • Table 108. BNC Global Introduction and Business Overview
  • Table 109. BNC Global Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 110. BNC Global Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 111. BNC Global Recent Development
  • Table 112. BMI KOREA Company Information
  • Table 113. BMI KOREA Introduction and Business Overview
  • Table 114. BMI KOREA Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 115. BMI KOREA Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 116. BMI KOREA Recent Development
  • Table 117. BNF Solution Company Information
  • Table 118. BNF Solution Introduction and Business Overview
  • Table 119. BNF Solution Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 120. BNF Solution Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 121. BNF Solution Recent Development
  • Table 122. Nanjing Letop Biotechnology Company Information
  • Table 123. Nanjing Letop Biotechnology Introduction and Business Overview
  • Table 124. Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 125. Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 126. Nanjing Letop Biotechnology Recent Development
  • Table 127. Topscience Biotech Company Information
  • Table 128. Topscience Biotech Introduction and Business Overview
  • Table 129. Topscience Biotech Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 130. Topscience Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 131. Topscience Biotech Recent Development
  • Table 132. Freda Biotechnology Company Information
  • Table 133. Freda Biotechnology Introduction and Business Overview
  • Table 134. Freda Biotechnology Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 135. Freda Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 136. Freda Biotechnology Recent Development
  • Table 137. Shebah Biotech Company Information
  • Table 138. Shebah Biotech Introduction and Business Overview
  • Table 139. Shebah Biotech Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 140. Shebah Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 141. Shebah Biotech Recent Development
  • Table 142. APR Corporation Company Information
  • Table 143. APR Corporation Introduction and Business Overview
  • Table 144. APR Corporation Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 145. APR Corporation Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 146. APR Corporation Recent Development
  • Table 147. Kolmar Korea Company Information
  • Table 148. Kolmar Korea Introduction and Business Overview
  • Table 149. Kolmar Korea Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 150. Kolmar Korea Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 151. Kolmar Korea Recent Development
  • Table 152. PORIBIO INC. Company Information
  • Table 153. PORIBIO INC. Introduction and Business Overview
  • Table 154. PORIBIO INC. Polydeoxyribonudeotide (PDRN) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 155. PORIBIO INC. Polydeoxyribonudeotide (PDRN) Product Offerings
  • Table 156. PORIBIO INC. Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Polydeoxyribonudeotide (PDRN) Downstream Customers
  • Table 160. Polydeoxyribonudeotide (PDRN) Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Polydeoxyribonudeotide (PDRN) Product Picture
  • Figure 2. Global Polydeoxyribonudeotide (PDRN) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Polydeoxyribonudeotide (PDRN) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Polydeoxyribonudeotide (PDRN) Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Polydeoxyribonudeotide (PDRN) Sales Price (2020-2031) & (US$/g)
  • Figure 6. Polydeoxyribonudeotide (PDRN) Report Years Considered
  • Figure 7. Global Polydeoxyribonudeotide (PDRN) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Polydeoxyribonudeotide (PDRN) Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polydeoxyribonudeotide (PDRN) Revenue in 2024
  • Figure 10. Polydeoxyribonudeotide (PDRN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Powder Picture
  • Figure 12. Solution Picture
  • Figure 13. Global Polydeoxyribonudeotide (PDRN) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Polydeoxyribonudeotide (PDRN) Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Polydeoxyribonudeotide (PDRN) Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Polydeoxyribonudeotide (PDRN) Price by Type (2020-2031) & (US$/g)
  • Figure 18. Product Picture of Mesotherapy
  • Figure 19. Product Picture of Bone Injection & Dermal Fillers
  • Figure 20. Product Picture of Pharmaceutical
  • Figure 21. Product Picture of Cosmetic
  • Figure 22. Product Picture of Wound Healing Products and Others
  • Figure 23. Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Polydeoxyribonudeotide (PDRN) Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 26. Global Polydeoxyribonudeotide (PDRN) Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Polydeoxyribonudeotide (PDRN) Price by Application (2020-2031) & (US$/g)
  • Figure 28. North America Polydeoxyribonudeotide (PDRN) Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Volume (%), (2020-2031)
  • Figure 40. United States Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Polydeoxyribonudeotide (PDRN) Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Polydeoxyribonudeotide (PDRN) Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Polydeoxyribonudeotide (PDRN) Industrial Chain
  • Figure 62. Polydeoxyribonudeotide (PDRN) Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed